Cannapharmarx ( (CPMD) ) just unveiled an update.
Cannapharmarx has appointed Constantine Nkafu as the interim CEO, who has been managing the company’s operations for several months. Nkafu, who also serves as the CEO of a subsidiary, brings extensive experience in the pharmaceutical, cannabis, and medical device industries, and has been instrumental in setting up and running complex operations. In addition, the company has appointed Amir Tal, Constantine Nkafu, and Elliot Zemel to its Board of Directors as part of an agreement with LTB Management, LLC. Nkafu and Zemel, both authorized by Health Canada to serve as directors, bring significant expertise and networks in the cannabis industry, which could enhance the company’s strategic positioning.
More about Cannapharmarx
Technical Sentiment Signal: Buy
Current Market Cap: $2.65M
For an in-depth examination of CPMD stock, go to TipRanks’ Stock Analysis page.